MedTrace Logo

The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine

NCT00145990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-03-05

No results posted yet for this study

Summary

To determine whether there is a difference in two different breathing tests used to detect asthma. Hypothesis: The Digidoser delivers less methacholine to the airways and will result in a higher PC20 than the value determined by the Rosenthal Dosimeter.

Conditions

Interventions

DRUG

methacholine

DEVICE

KoKo Digidoser

DEVICE

Rosethal Dosimeter

Sponsors & Collaborators

Principal Investigators

  • Yasmeen Khan, MD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00145990 on ClinicalTrials.gov